HOME
ABOUT US
SERVICES
ACCESS
FIND A DOCTOR
NEWS
CLINICAL RESEARCH
CLINICAL TRIAL
CONTACT
More
Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT1A somatodendritic autoreceptors in the dorsal raphe nucleus
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation
Cannabinoid Regulation of Acute and Anticipatory Nausea
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews
The cannabinoids: An overview. Therapeutic implications in vomiting and nausea after cancer chemotherapy, in appetite promotion, in multiple sclerosis and in neuroprotection
Cannabinoid-dopamine interaction in the pathophysiology and treatment of CNS disorders
Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures — A short review
Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor
Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations
Phytocannabinoids as novel therapeutic agents in CNS disorders
The effect of cannabichromene on adult neural stem/progenitor cells
Therapeutic Potential of Cannabinoids in CNS Disease
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain from Spinal Cord Injury and Disease
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy
Cannabinoids for Neuropathic Pain
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures
Cannabidiol administration after hypoxiaeischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Cannabidiol and (-)D9-tetrahydrocannabinol are neuroprotective antioxidants
Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
Cannabidiol, neuroprotection and neuropsychiatric disorders
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement
Cannabinoid CB2 receptor: a new target for controlling neural cell survival?
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis
Cannabinoids and neuroprotection in basal ganglia disorders
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects
Cannabinoids: Well-Suited Candidates for the Treatment of Perinatal Brain Injury
CB1 Cannabinoid Receptors and On-Demand Defense Against Excitotoxicity
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity
Endocannabinoids and traumatic brain injury
Endocannabinoids in the Retina: From Marijuana to Neuroprotection
Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection
Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling
Molecular Mechanisms of Cannabinoid Protection from Neuronal Excitotoxicity
Neuroprotection by Δ9-Tetrahydrocannabinol, the Main Active Compound in Marijuana, against Ouabain-Induced In Vivo Excitotoxicity
Neuroprotective and Blood-Retinal Barrier-Preserving Effects of Cannabidiol in Experimental Diabetes
Neuroprotective antioxidants from marijuana
Nonpsychoactive Cannabidiol Prevents Prion Accumulation and Protects Neurons against Prion Toxicity
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist
Prospects for cannabinoid therapies in basal ganglia disorders
Protective effects of Δ9-tetrahydrocannabinol against N-methyl-D-aspartate-induced AF5 cell death
The Cannabinoid WIN55212-2 Promotes Neural Repair After Neonatal Hypoxia–Ischemia
The CB₁ cannabinoid receptor signals striatal neuroprotection via a PI3K/Akt/mTORC1/BDNF pathway
The endocannabinoid 2-AG protects the blood–brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines
The endocannabinoid system as a target for the treatment of neurodegenerative disease
The endocannabinoid system in normal and pathological brain ageing
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects
Expression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: Growth inhibition by receptor activation
An Increase in the Omega-6/Omega-3 Fatty Acid Ratio Increases the Risk for Obesity
Dietary Omega-6/Omega-3 and Endocannabinoids: Implications for Brain Health and Diseases
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions
The Composition of Hemp Seed Oil and Its Potential as an Important Source of Nutrition
The importance of the ratio of omega-6/omega-3 essential fatty acids
